Insider Trading: Dynavax Technologies Corp (DVAX.A)

DVAX.A on American Stock Exchange

2.52USD
17 May 2013
Price Change (% chg)

$0.03 (+1.20%)
Prev Close
$2.49
Open
$2.49
Day's High
$2.55
Day's Low
$2.44
Volume
83,139
Avg. Vol
91,799
52-wk High
$5.08
52-wk Low
$1.75

Search Stocks
ORONSKY ARNOLD L Options Exercised: 0
Trade Date: Monday, 1 Aug 2011 Price: 0.00
Title: Director Shares Held: 29,008
Type Traded: Indirect Net Change in Shares This Filing: -555,315
» More Insider Trading

Institutional Holders

% Shares Owned: 86.32%
# of Holders: 139
Total Shares Held: 157,863,595
3 Mo. Net Change: -3,060,460
# New Positions: 22
# Closed Positions: 31
# Increased Positions: 72
# Reduced Positions: 61
# Net Buyers: 11

Officers & Directors

Name Age Since Current Position

Arnold Oronsky

 73 2006 Independent Chairman of the Board

J. Tyler Martin

 2010 President, Chief Medical Officer, Director

Eddie Gray

 2013 Chief Executive Officer, Director

Zbigniew Janowicz

 61 2006 Chief Executive Officer, Managing Director of Rhein Biotech GmbH (Dynavax Europe)

David Novack

 50 2013 Senior Vice President - Operations and Quality

Jennifer Lew

 39 2009 Vice President - Finance, Principal Accounting Officer

Robert Coffman

 65 2000 Vice President, Chief Scientific Officer

Michael Ostrach

 60 2006 Vice President, Chief Business Officer, General Counsel

David Happel

 2012 Vice President - Global Sales and Marketing

Dino Dina

 2013 Director

Francis Cano

 65 2009 Independent Director

Dennis Carson

 65 1997 Independent Director

Denise Gilbert

 54 2004 Independent Director

Daniel Kisner

 65 2010 Independent Director

Peggy Phillips

 58 2006 Independent Director

Stanley Plotkin

 79 2005 Independent Director
Search Stocks